Recent Patents on Inflammation & Allergy Drug Discovery
Title:Advances in Developing Prophylactics and Therapeutics to Counter Inflammatory, Allergic and Infectious Diseases
Volume: 12 Issue: 1
Author(s): Ashok Munjal, Hafiz M.N. Iqbal and Kuldeep Dhama
Affiliation:
Export Options
About this article
Cite this article as:
Munjal Ashok , Iqbal M.N. Hafiz and Dhama Kuldeep , Advances in Developing Prophylactics and Therapeutics to Counter Inflammatory, Allergic and Infectious Diseases, Recent Patents on Inflammation & Allergy Drug Discovery 2018; 12 (1) . https://dx.doi.org/10.2174/1872213X1201180821095512
DOI https://dx.doi.org/10.2174/1872213X1201180821095512 |
Print ISSN 1872-213X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-2710 |
Related Articles
-
Nanoparticles, Neurotoxicity and Neurodegenerative Diseases
Current Drug Metabolism Overview of Base Excision Repair Biochemistry
Current Molecular Pharmacology Cytokines as Regulators of Atherosclerosis in Murine Models
Current Drug Targets High-throughput Genotyping Methods for Pharmacogenomic Studies
Current Pharmacogenomics Pharmacological Assessment of Ugi Multicomponent Reaction: Rapid and Green Synthesis of Novel Biological Agents
Current Bioactive Compounds Salivary Gland Dysplasia in Fgf10 Heterozygous Mice: A New Mouse Model of Xerostomia
Current Molecular Medicine The Endothelin Axis as Therapeutic Target in Human Malignancies: Present and Future
Current Pharmaceutical Design Reintroduction of Cow’s Milk in Milk-Allergic Children
Endocrine, Metabolic & Immune Disorders - Drug Targets Monoclonal Antibodies: A Review
Current Clinical Pharmacology Ductal Carcinoma In Situ: Clinical Trials Update and Resolving Controversies
Current Cancer Therapy Reviews β-arrestin-Biased Agonism at the Parathyroid Hormone Receptor Uncouples Bone Formation from Bone Resorption
Endocrine, Metabolic & Immune Disorders - Drug Targets Non-Peptidic Small-Molecule Antagonists of the Human Platelet Thrombin Receptor PAR-1
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Glucocorticoids Selectively Inhibit Paclitaxel-Induced Apoptosis: Mechanisms and Its Clinical Impact
Current Medicinal Chemistry Relation between Soluble CD14 Levels, Inflammation, Subclinical Atherosclerosis and Mortality in Hemodialysis Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets Activated Protein C: A Promising Drug with Multiple Effects?
Mini-Reviews in Medicinal Chemistry Pharmacological Implications of MMP-9 Inhibition by ACE Inhibitors
Current Medicinal Chemistry Non-pigmenting Fixed Drug Eruption: An Unusual Adverse Reaction to Aceclofenac
Current Drug Safety Vascular Disease and Risk Factors in Chronic Kidney Disease
Vascular Disease Prevention (Discontinued) Biological and Pharmacological Properties of Myrtenol: A Review
Current Pharmaceutical Design Flavonoids as Potential Anti-Allergic Substances
Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents